Rosiglitazone reduces insulin resistance, an underlying defect of type 2 diabetes.
More information
More information
Subcategories 1
Sites 3
Official product site with information primarily intended for diabetics. Includes patient and prescribing information.
Features information about dosage, usage, warnings, and side effects.
Potential safety issue related to Avandia (rosiglitazone), a drug approved to treat type 2 diabetes.
(May 21, 2007)
Features information about dosage, usage, warnings, and side effects.
Official product site with information primarily intended for diabetics. Includes patient and prescribing information.
Potential safety issue related to Avandia (rosiglitazone), a drug approved to treat type 2 diabetes.
(May 21, 2007)
